Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 120 entries
Sorted by: Best Match Show Resources per page
SGLT-2 inhibitors and their potential in the treatment of diabetes.

Diabetes, metabolic syndrome and obesity : targets and therapy

Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ.
PMID: 24348059
Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416.

Diabetes remains a burgeoning global problem, necessitating ongoing efforts on the part of pharmaceutical and device manufacturers, patients, and society to curb the frightening trends in morbidity and mortality attributable to the malady. Since 1835 when phlorizin was discovered,...

Cite
Rosenwasser RF, Sultan S, Sutton D, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013;6:453-67doi: 10.2147/DMSO.S34416.
Rosenwasser, R. F., Sultan, S., Sutton, D., Choksi, R., & Epstein, B. J. (2013). SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes, metabolic syndrome and obesity : targets and therapy, 6453-67. https://doi.org/10.2147/DMSO.S34416
Rosenwasser, Rebecca F, et al. "SGLT-2 inhibitors and their potential in the treatment of diabetes." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 6 (2013): 453-67. doi: https://doi.org/10.2147/DMSO.S34416
Rosenwasser RF, Sultan S, Sutton D, Choksi R, Epstein BJ. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes. 2013 Nov 27;6:453-67. doi: 10.2147/DMSO.S34416. PMID: 24348059; PMCID: PMC3848644.
Copy Download .nbib Format: NLM
Allergen immunotherapy for allergic asthma: protocol for a systematic review.

Clinical and translational allergy

Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A.
PMID: 26862389
Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015.

BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in...

Cite
Dhami S, Nurmatov U, Agache I, et al. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016;6:5doi: 10.1186/s13601-016-0094-y.
Dhami, S., Nurmatov, U., Agache, I., Lau, S., Muraro, A., Jutel, M., Roberts, G., Akdis, C., Bonini, M., Calderon, M., Casale, T., Cavkaytar, O., Cox, L., Demoly, P., Flood, B., Hamelmann, E., Izuhara, K., Kalayci, �. �., Kleine-Tebbe, J., Nieto, A., Papadopoulos, N., Pfaar, O., Rosenwasser, L., Ryan, D., Schmidt-Weber, C., Szefler, S., Wahn, U., van Wijk, R. G., Wilkinson, J., & Sheikh, A. (2015). Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clinical and translational allergy, 65. https://doi.org/10.1186/s13601-016-0094-y
Dhami, Sangeeta, et al. "Allergen immunotherapy for allergic asthma: protocol for a systematic review." Clinical and translational allergy vol. 6 (2015): 5. doi: https://doi.org/10.1186/s13601-016-0094-y
Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, Roberts G, Akdis C, Bonini M, Calderon M, Casale T, Cavkaytar O, Cox L, Demoly P, Flood B, Hamelmann E, Izuhara K, Kalayci Ö, Kleine-Tebbe J, Nieto A, Papadopoulos N, Pfaar O, Rosenwasser L, Ryan D, Schmidt-Weber C, Szefler S, Wahn U, van Wijk RG, Wilkinson J, Sheikh A. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2016 Feb 09;6:5. doi: 10.1186/s13601-016-0094-y. eCollection 2015. PMID: 26862389; PMCID: PMC4746770.
Copy Download .nbib Format: NLM
Rewiring Host Lipid Metabolism by Large Viruses Determines the Fate of Emiliania huxleyi, a Bloom-Forming Alga in the Ocean.

The Plant cell

Rosenwasser S, Mausz MA, Schatz D, Sheyn U, Malitsky S, Aharoni A, Weinstock E, Tzfadia O, Ben-Dor S, Feldmesser E, Pohnert G, Vardi A.
PMID: 24920329
Plant Cell. 2014 Jun;26(6):2689-2707. doi: 10.1105/tpc.114.125641. Epub 2014 Jun 10.

Marine viruses are major ecological and evolutionary drivers of microbial food webs regulating the fate of carbon in the ocean. We combined transcriptomic and metabolomic analyses to explore the cellular pathways mediating the interaction between the bloom-forming coccolithophore Emiliania...

Cite
Rosenwasser S, Mausz MA, Schatz D, et al. Rewiring Host Lipid Metabolism by Large Viruses Determines the Fate of Emiliania huxleyi, a Bloom-Forming Alga in the Ocean. Plant Cell. 2014;26(6):2689-2707doi: 10.1105/tpc.114.125641.
Rosenwasser, S., Mausz, M. A., Schatz, D., Sheyn, U., Malitsky, S., Aharoni, A., Weinstock, E., Tzfadia, O., Ben-Dor, S., Feldmesser, E., Pohnert, G., & Vardi, A. (2014). Rewiring Host Lipid Metabolism by Large Viruses Determines the Fate of Emiliania huxleyi, a Bloom-Forming Alga in the Ocean. The Plant cell, 26(6), 2689-2707. https://doi.org/10.1105/tpc.114.125641
Rosenwasser, Shilo, et al. "Rewiring Host Lipid Metabolism by Large Viruses Determines the Fate of Emiliania huxleyi, a Bloom-Forming Alga in the Ocean." The Plant cell vol. 26,6 (2014): 2689-2707. doi: https://doi.org/10.1105/tpc.114.125641
Rosenwasser S, Mausz MA, Schatz D, Sheyn U, Malitsky S, Aharoni A, Weinstock E, Tzfadia O, Ben-Dor S, Feldmesser E, Pohnert G, Vardi A. Rewiring Host Lipid Metabolism by Large Viruses Determines the Fate of Emiliania huxleyi, a Bloom-Forming Alga in the Ocean. Plant Cell. 2014 Jun;26(6):2689-2707. doi: 10.1105/tpc.114.125641. Epub 2014 Jun 10. PMID: 24920329; PMCID: PMC4114960.
Copy Download .nbib Format: NLM
Therapeutic options for endovascular therapy for intracranial aneurysms.

Neurosurgical focus

Armonda RA, Thomas JE, Rosenwasser RH.
PMID: 17112215
Neurosurg Focus. 1998 Oct 15;5(4):e4. doi: 10.3171/foc.1998.5.4.5.

Endovascular surgical technology is in the early stages of evolution. A critical phase of this development has been microcatheter technology, which has permitted sufficiently precise intravascular navigation to safely engage the lumen of the aneurysm itself. Digital subtraction angiography,...

Cite
Armonda RA, Thomas JE, Rosenwasser RH. Therapeutic options for endovascular therapy for intracranial aneurysms. Neurosurg Focus. 1998;5(4):e4doi: 10.3171/foc.1998.5.4.5.
Armonda, R. A., Thomas, J. E., & Rosenwasser, R. H. (1998). Therapeutic options for endovascular therapy for intracranial aneurysms. Neurosurgical focus, 5(4), e4. https://doi.org/10.3171/foc.1998.5.4.5
Armonda, R A, et al. "Therapeutic options for endovascular therapy for intracranial aneurysms." Neurosurgical focus vol. 5,4 (1998): e4. doi: https://doi.org/10.3171/foc.1998.5.4.5
Armonda RA, Thomas JE, Rosenwasser RH. Therapeutic options for endovascular therapy for intracranial aneurysms. Neurosurg Focus. 1998 Oct 15;5(4):e4. doi: 10.3171/foc.1998.5.4.5. PMID: 17112215.
Copy Download .nbib Format: NLM
The RASL procedure: reduction and association of the scaphoid and lunate using the Herbert screw.

Techniques in hand & upper extremity surgery

Rosenwasser MP, Miyasajsa KC, Strauch RJ.
PMID: 16609495
Tech Hand Up Extrem Surg. 1997 Dec;1(4):263-72.

No abstract available.

Cite
Rosenwasser MP, Miyasajsa KC, Strauch RJ. The RASL procedure: reduction and association of the scaphoid and lunate using the Herbert screw. Tech Hand Up Extrem Surg. 1997;1(4):263-72
Rosenwasser, M. P., Miyasajsa, K. C., & Strauch, R. J. (1997). The RASL procedure: reduction and association of the scaphoid and lunate using the Herbert screw. Techniques in hand & upper extremity surgery, 1(4), 263-72.
Rosenwasser, M P, et al. "The RASL procedure: reduction and association of the scaphoid and lunate using the Herbert screw." Techniques in hand & upper extremity surgery vol. 1,4 (1997): 263-72.
Rosenwasser MP, Miyasajsa KC, Strauch RJ. The RASL procedure: reduction and association of the scaphoid and lunate using the Herbert screw. Tech Hand Up Extrem Surg. 1997 Dec;1(4):263-72. PMID: 16609495.
Copy Download .nbib Format: NLM
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.

Neurosurgery

Veznedaroglu E, Andrews DW, Benitez RP, Downes MB, Werner-Wasik M, Rosenstock J, Curran WJ, Rosenwasser RH.
PMID: 18596429
Neurosurgery. 2008 Feb;62:763-75. doi: 10.1227/01.neu.0000316280.99500.99.

OBJECTIVE: Despite the success of stereotactic radiosurgery, large inoperable arteriovenous malformations (AVMs) of 14 cm3 or more have remained largely refractory to stereotactic radiosurgery, with much lower obliteration rates. We review treatment of large AVMs either previously untreated or...

Cite
Veznedaroglu E, Andrews DW, Benitez RP, et al. Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery. 2008;62:763-75doi: 10.1227/01.neu.0000316280.99500.99.
Veznedaroglu, E., Andrews, D. W., Benitez, R. P., Downes, M. B., Werner-Wasik, M., Rosenstock, J., Curran, W. J., & Rosenwasser, R. H. (2008). Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery, 62763-75. https://doi.org/10.1227/01.neu.0000316280.99500.99
Veznedaroglu, Erol, et al. "Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization." Neurosurgery vol. 62 (2008): 763-75. doi: https://doi.org/10.1227/01.neu.0000316280.99500.99
Veznedaroglu E, Andrews DW, Benitez RP, Downes MB, Werner-Wasik M, Rosenstock J, Curran WJ, Rosenwasser RH. Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery. 2008 Feb;62:763-75. doi: 10.1227/01.neu.0000316280.99500.99. PMID: 18596429.
Copy Download .nbib Format: NLM
One Year With WAO Journal.

The World Allergy Organization journal

Ring J, Rosenwasser L.
PMID: 23282846
World Allergy Organ J. 2008 Dec;1(12):192-3. doi: 10.1097/WOX.0b013e318194c119.

No abstract available.

Cite
Ring J, Rosenwasser L. One Year With WAO Journal. World Allergy Organ J. 2008;1(12):192-3doi: 10.1097/WOX.0b013e318194c119.
Ring, J., & Rosenwasser, L. (2008). One Year With WAO Journal. The World Allergy Organization journal, 1(12), 192-3. https://doi.org/10.1097/WOX.0b013e318194c119
Ring, Johannes, and Rosenwasser, Lanny. "One Year With WAO Journal." The World Allergy Organization journal vol. 1,12 (2008): 192-3. doi: https://doi.org/10.1097/WOX.0b013e318194c119
Ring J, Rosenwasser L. One Year With WAO Journal. World Allergy Organ J. 2008 Dec;1(12):192-3. doi: 10.1097/WOX.0b013e318194c119. PMID: 23282846; PMCID: PMC3651018.
Copy Download .nbib Format: NLM
What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007.

The World Allergy Organization journal

Del Giacco S, Rosenwasser LJ, Crisci CD, Frew AJ, Kaliner MA, Lee BW, Guanghui L, Maspero J, Moon HB, Takemasa N, Potter PC, Singh AB, Valovirta E, Vervloet D, Warner JO, Henley K.
PMID: 23283298
World Allergy Organ J. 2008 Jan;1(1):19-20. doi: 10.1097/wox.0b013e3181651679.

No abstract available.

Cite
Del Giacco S, Rosenwasser LJ, Crisci CD, et al. What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007. World Allergy Organ J. 2008;1(1):19-20doi: 10.1097/wox.0b013e3181651679.
Del Giacco, S., Rosenwasser, L. J., Crisci, C. D., Frew, A. J., Kaliner, M. A., Lee, B. W., Guanghui, L., Maspero, J., Moon, H. B., Takemasa, N., Potter, P. C., Singh, A. B., Valovirta, E., Vervloet, D., Warner, J. O., Henley, K. (2008). What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007. The World Allergy Organization journal, 1(1), 19-20. https://doi.org/10.1097/wox.0b013e3181651679
Del Giacco, Sergio, et al. "What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007." The World Allergy Organization journal vol. 1,1 (2008): 19-20. doi: https://doi.org/10.1097/wox.0b013e3181651679
Del Giacco S, Rosenwasser LJ, Crisci CD, Frew AJ, Kaliner MA, Lee BW, Guanghui L, Maspero J, Moon HB, Takemasa N, Potter PC, Singh AB, Valovirta E, Vervloet D, Warner JO, Henley K. What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007. World Allergy Organ J. 2008 Jan;1(1):19-20. doi: 10.1097/wox.0b013e3181651679. PMID: 23283298; PMCID: PMC3650953.
Copy Download .nbib Format: NLM
Revision wrist arthroscopy after failed primary arthroscopic treatment.

Journal of wrist surgery

Jang E, Danoff JR, Rajfer RA, Rosenwasser MP.
PMID: 24533243
J Wrist Surg. 2014 Feb;3(1):30-6. doi: 10.1055/s-0033-1364090.

UNLABELLED: Background The etiologies and outcomes of cases of failed therapeutic wrist arthroscopy have not been well-described to date. Purpose The purposes of this study were to identify common preventable patterns of failure in wrist arthroscopy and to report...

Cite
Jang E, Danoff JR, Rajfer RA, et al. Revision wrist arthroscopy after failed primary arthroscopic treatment. J Wrist Surg. 2014;3(1):30-6doi: 10.1055/s-0033-1364090.
Jang, E., Danoff, J. R., Rajfer, R. A., & Rosenwasser, M. P. (2014). Revision wrist arthroscopy after failed primary arthroscopic treatment. Journal of wrist surgery, 3(1), 30-6. https://doi.org/10.1055/s-0033-1364090
Jang, Eugene, et al. "Revision wrist arthroscopy after failed primary arthroscopic treatment." Journal of wrist surgery vol. 3,1 (2014): 30-6. doi: https://doi.org/10.1055/s-0033-1364090
Jang E, Danoff JR, Rajfer RA, Rosenwasser MP. Revision wrist arthroscopy after failed primary arthroscopic treatment. J Wrist Surg. 2014 Feb;3(1):30-6. doi: 10.1055/s-0033-1364090. PMID: 24533243; PMCID: PMC3922874.
Copy Download .nbib Format: NLM
Critical Documents on Cow's Milk Allergy and Anaphylaxis: Two Recent WAO Position Papers.

The World Allergy Organization journal

Rosenwasser LJ.
PMID: 23282441
World Allergy Organ J. 2011 May;4(5):76. doi: 10.1097/WOX.0b013e31821e9e45.

No abstract available.

Cite
Rosenwasser LJ. Critical Documents on Cow's Milk Allergy and Anaphylaxis: Two Recent WAO Position Papers. World Allergy Organ J. 2011;4(5):76doi: 10.1097/WOX.0b013e31821e9e45.
Rosenwasser, L. J. (2011). Critical Documents on Cow's Milk Allergy and Anaphylaxis: Two Recent WAO Position Papers. The World Allergy Organization journal, 4(5), 76. https://doi.org/10.1097/WOX.0b013e31821e9e45
Rosenwasser, Lanny J. "Critical Documents on Cow's Milk Allergy and Anaphylaxis: Two Recent WAO Position Papers." The World Allergy Organization journal vol. 4,5 (2011): 76. doi: https://doi.org/10.1097/WOX.0b013e31821e9e45
Rosenwasser LJ. Critical Documents on Cow's Milk Allergy and Anaphylaxis: Two Recent WAO Position Papers. World Allergy Organ J. 2011 May;4(5):76. doi: 10.1097/WOX.0b013e31821e9e45. PMID: 23282441; PMCID: PMC3651112.
Copy Download .nbib Format: NLM
Introduction to the new editorial series, notes of allergy watchers.

The World Allergy Organization journal

Rosenwasser LJ.
PMID: 23283010
World Allergy Organ J. 2009 May;2(5):61. doi: 10.1097/WOX.0b013e3181a5d3b4.

No abstract available.

Cite
Rosenwasser LJ. Introduction to the new editorial series, notes of allergy watchers. World Allergy Organ J. 2009;2(5):61doi: 10.1097/WOX.0b013e3181a5d3b4.
Rosenwasser, L. J. (2009). Introduction to the new editorial series, notes of allergy watchers. The World Allergy Organization journal, 2(5), 61. https://doi.org/10.1097/WOX.0b013e3181a5d3b4
Rosenwasser, Lanny J. "Introduction to the new editorial series, notes of allergy watchers." The World Allergy Organization journal vol. 2,5 (2009): 61. doi: https://doi.org/10.1097/WOX.0b013e3181a5d3b4
Rosenwasser LJ. Introduction to the new editorial series, notes of allergy watchers. World Allergy Organ J. 2009 May;2(5):61. doi: 10.1097/WOX.0b013e3181a5d3b4. PMID: 23283010; PMCID: PMC3651028.
Copy Download .nbib Format: NLM
Flow-diversion panacea or poison?.

Frontiers in neurology

Zanaty M, Chalouhi N, Tjoumakaris SI, Rosenwasser RH, Gonzalez LF, Jabbour P.
PMID: 24592254
Front Neurol. 2014 Feb 28;5:21. doi: 10.3389/fneur.2014.00021. eCollection 2014.

Endovascular therapy is now the treatment of choice for intracranial aneurysms (IAs) for its efficacy and safety profile. The use of flow diversion (FD) has recently expanded to cover many types of IAs in various locations. Some institutions even...

Cite
Zanaty M, Chalouhi N, Tjoumakaris SI, et al. Flow-diversion panacea or poison?. Front Neurol. 2014;5:21doi: 10.3389/fneur.2014.00021.
Zanaty, M., Chalouhi, N., Tjoumakaris, S. I., Rosenwasser, R. H., Gonzalez, L. F., & Jabbour, P. (2014). Flow-diversion panacea or poison?. Frontiers in neurology, 521. https://doi.org/10.3389/fneur.2014.00021
Zanaty, Mario, et al. "Flow-diversion panacea or poison?." Frontiers in neurology vol. 5 (2014): 21. doi: https://doi.org/10.3389/fneur.2014.00021
Zanaty M, Chalouhi N, Tjoumakaris SI, Rosenwasser RH, Gonzalez LF, Jabbour P. Flow-diversion panacea or poison?. Front Neurol. 2014 Feb 28;5:21. doi: 10.3389/fneur.2014.00021. eCollection 2014. PMID: 24592254; PMCID: PMC3938101.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 120 entries